Paper · 41358893
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care, 2026. Cited by 290 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Papers, record 41358893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41358893
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus | Major topic |
| Standard of Care | Major topic |
| Humans |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References224
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,180,194 | An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31180194 | PubMed |
| 2 | 23,744,306 | The use of intermediate endpoints in the design of type 1 diabetes prevention trials. | Diabetologia | 2013 | https://conductscience.org/library/papers/23744306 | PubMed |
| 3 | 32,451,571 | Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes? | Diabetologia | 2020 | https://conductscience.org/library/papers/32451571 | PubMed |
| 4 | 15,951,574 | Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15951574 | PubMed |
| 5 | 30,617,141 | Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism. | Diabetes Care | 2019 | https://conductscience.org/library/papers/30617141 | PubMed |
| 6 | 25,917,553 | Emerging treatments for post-transplantation diabetes mellitus. | Nat Rev Nephrol | 2015 | https://conductscience.org/library/papers/25917553 | PubMed |
| 7 | 28,605,777 | Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels. | Ann Intern Med | 2017 | https://conductscience.org/library/papers/28605777 | PubMed |
| 8 | 36,537,518 | ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. | Pediatr Diabetes | 2022 | https://conductscience.org/library/papers/36537518 | PubMed |
| 9 | 18,463,375 | Hyperglycemia and adverse pregnancy outcomes. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18463375 | PubMed |
| 10 | 23,723,353 | No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes. | Diabetes Care | 2013 | https://conductscience.org/library/papers/23723353 | PubMed |
1 to 10 of 224
See all 224 referencesCited by278
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 290 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,985,628 | Diagnostic Performance of Triglyceride-Glucose Body Mass Index (TyG-BMI), Fibrosis-4 Index (FIB-4), and Their Combined Model for Clinically Significant Liver Fibrosis in Type 2 Diabetes Mellitus. | Cureus | 2026 | https://conductscience.org/library/papers/42985628 | PubMed |
| 42,983,401 | Fatty liver index-defined hepatic steatosis and impaired fasting glucose differentially associate with incident diabetes and cardiovascular events in older adults: a nationwide cohort study. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/42983401 | PubMed |
| 42,975,257 | Diabetic Ketoacidosis at Diagnosis is Associated With Adverse Long-Term Glycaemic Trajectories and Retinopathy in Adult-Onset Type 1 Diabetes. A Single-Centre Retrospective Cohort Study. | Diabetes Metab Res Rev | 2026 | https://conductscience.org/library/papers/42975257 | PubMed |
| 42,973,838 | Leveraging machine learning methods to predict post-transplant diabetes in solid organ transplant recipients. | J Endocr Soc | 2026 | https://conductscience.org/library/papers/42973838 | PubMed |
| 42,970,541 | Compare 30-minute automated office blood pressure vs 24-hour ambulatory blood pressure monitoring: A prospective study. | PLoS One | 2026 | https://conductscience.org/library/papers/42970541 | PubMed |
| 42,959,035 | Behavioral-metabolic phenotypes and differential risks of diabetic kidney disease and peripheral neuropathy in type 2 diabetes: a latent class analysis. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42959035 | PubMed |
| 42,957,849 | Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42957849 | PubMed |
| 42,952,650 | Serum β-defensin-3 and inflammatory markers for discriminating diabetic foot infection and infection severity: a retrospective study. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42952650 | PubMed |
| 42,952,517 | Association of baseline glycaemic status with BMD change after 12 doses of romosozumab: a retrospective cohort study of 170 patients. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42952517 | PubMed |
| 42,952,496 | Glycemic biomarkers and cardiovascular disease in diabetes: a comparative analysis of population-based and clinical cohorts. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42952496 | PubMed |
1 to 10 of 278
See all 278 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41358893
GET https://conductscience.org/api/papers/v1/41358893/references?page=2